12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Deals

Genzyme, LabCorp deal

LabCorp will acquire Genzyme's Genzyme Genetics testing business for $925 million in cash. LabCorp said the deal will expand its capabilities in reproductive, genetic, hematology, oncology and clinical trials central laboratory testing. According to Genzyme, LabCorp has committed to offer employment to...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >